Russian assets of Henkel can be bought by Pharmstandard shareholders and Kismet Capital

Henkel is in the final stages of the sale of Russian assets, a company representative told Vedomosti. He declined to name the buyer, noting that the agreement had not yet been signed. According to the sources of the newspaper, a consortium of investors, which includes shareholders of the pharmaceutical manufacturer Pharmstandard (owned by Viktor Kharitonin and Yegor Kulkov), Kismet Capital investment company Ivan Tavrin and the founders of the Elbrus Capital fund, can act as a buyer of 11 plants.

Henkel, headquartered in Düsseldorf, has been operating in Russia since 1990. It produces products under the brands Persil, Bref, Vernel, Pemolux, Pemos, Laska, Deni, Moment glue at 11 Russian factories in the Moscow region, Perm, Saratov, Leningrad, Ulyanovsk regions and the Stavropol Territory.

The shareholders of Pharmstandard will become the majority owners. According to Vedomosti, a government commission has already issued a permit for the deal. It is alleged that after the sale, the factories will continue to produce products under the Henkel brand. However, as Kommersant reported in December, Sergei Bykovsky, general director of the German company’s representative office in Russia, told suppliers that the company would operate in the Russian Federation as an independent organization under the Lab Industries brand.

The government, Pharmstandard, Kismet Capital and Elbrus Capital have not yet commented on the information. The amount of the sale was not disclosed. At the end of 2022, Kommersant’s sources reported that Henkel estimated assets at more than €500 million.

About Russian assets – in the material “Kommersant” “Henkel is laundered from Russia.”

Leonid Uvarchev

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.